{"disease":{"id":"sickle-cell-disease-hemolytic-anemia","name":"sickle cell disease hemolytic anemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07566494","title":"Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":25,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}